(19)
(11) EP 2 263 090 A1

(12)

(43) Date of publication:
22.12.2010 Bulletin 2010/51

(21) Application number: 09731007.2

(22) Date of filing: 03.04.2009
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
(86) International application number:
PCT/US2009/002120
(87) International publication number:
WO 2009/126232 (15.10.2009 Gazette 2009/42)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 07.04.2008 US 78857

(71) Applicant: Blanchette Rockefeller Neurosciences Institute
Morgantown, WV 26506-9301 (US)

(72) Inventors:
  • KHAN, Tapan, Kumar
    Morgantown WV 26505 (US)
  • ALKON, Daniel, L.
    Bethesda MD 20817 (US)

(74) Representative: Kador & Partner 
Corneliusstrasse 15
80469 München
80469 München (DE)

   


(54) ALZHEIMER'S DISEASE-SPECIFIC ALTERATIONS OF THE ERK1/ERK2 PHOSPHORYLATION RATIO-ALZHEIMER'S DISEASE-SPECIFIC MOLECULAR BIOMARKERS (ADSMB)